Infarct artery reocclusion after primary angioplasty, stent placement, and thrombolytic therapy for acute myocardial infarction

American Heart Journal

Volumn 141, Issue 5, 2001, Pages 704-710

  Wilson, Stephanie H ^a   Bell, Malcolm R ^a   Rihal, Charanjit S ^a   Bailey, Kent R ^a   Holmes Jr, David R ^a   Berger, Peter B ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANISTREPLASE; FIBRINOLYTIC AGENT; PROUROKINASE; STREPTOKINASE; TISSUE PLASMINOGEN ACTIVATOR;

ACUTE HEART INFARCTION; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOVASCULAR DISEASE; CORONARY ARTERY DISEASE; CORONARY STENT; FIBRINOLYTIC THERAPY; HUMAN; INTRACORONARY INFUSION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RECURRENT DISEASE; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

EID: 0035029005     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1067/mhj.2001.114971     Document Type: Article

References (39)

1. The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction
2. Randomized trial of intravenous streptokinase, oral aspirin, both or neither among 17,187 cases of suspected acute myocardial infarction
3. Consequences of reocclusion after successful reperfusion therapy in acute myocardial infarction
4. Long-term implications of reocclusion on left ventricular size and function after successful thrombolysis for first anterior myocardial infarction
5. Aspirin versus Coumadin in the prevention of reocclusion and recurrent ischemia after successful thrombalysis: A prospective placebo-controlled angiographic study
6. Reocclusion three months after successful thrombolytic treatment of acute myocardial infarction with anisoylated plasminogen streptokinase activating complex
7. Primary coronary angioplasty vs thrombolytic therapy for acute myocardial infarction (MI): Long-term follow-up of ten randomized trials
8. Stenting for acute myocardial infarction
9. One-week and six-month angiographic controls of stent implantation after occlusive and nonocclusive dissection during primary balloon angiopiasty for acute myocardial infarction
10. Primary stent implantation without Coumadin in acute myocardial infarction
11. Reocclusion: The flip side of thrombolysis
12. Angiographic findings and catheterization laboratory events in patients with primary coronary angioplasty or streptokinase therapy for acute myocardial infarction
13. Serial angiographic follow-up after successful direct angioplasty for acute myocardial infarction
14. Six-month clinical and angiographic follow-up after direct angioplasty for acute myocardial infarction: Final results from the Primary Angioplasty Registry
15. Emergency percutaneous transluminal coronary angioplasty in acute myocardial infarction: A 3 year experience
16. Early and late results of coronary angioplasty without antecedent thrombolytic therapy from acute myocardial infarction
17. Emergency coronary angioplasty for acute myocardial infarction
18. Randomized trial of direct coronary angioplasty versus intravenous streptokinase in acute myocardial infarction
19. A prospective, randomized evaluation of prophylactic intraaortic balloon counterpulsation in high risk patients with acute myocardial infarction treated with primary angioplasty: Second Primary Angioplasty in Myocardial Infarction (PAMI-II) Trial Investigators
20. In-hospital and late results of coronary stents versus conventional balloon angioplasty in acute myocardial infarction (GRAMI trial)
21. A clinical trial comparing primary stenting of the infarct-related artery with optimal primary angioplasty for acute myocardial infarction: Results from the Florence Randomized Elective Stenting in Acute Coronary Occlusions (FRESCO) trial
22. Direct angioplasty and stenting of the infarct-related artery in acute myocardial infarction
23. Randomized comparison of primary stenting with primary balloon angioplasty in acute myocardial infarction
24. Incidence and predictors of angiographic restenosis and reocclusion after primary infarct stenting: Core lab analysis from the PAMI stent pilot trial
25. Angiographic evolution of coronary stenosis after thrombolytic therapy
26. Frequent reocclusion of patent infarct-related arteries between 4 weeks and 1 year: Effects of antiplatelet therapy
27. Compromise of beneficial effects of reperfusion of myocardium supplied by vessels with critical residual stenosis
28. A comparison of immediate coronary angioplasty with intravenous streptokinase in acute myocardial infarction
29. A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction
30. A clinical trial comparing primary coronary angioplasty with tissue plasminogen activator for acute myocardia infarction
31. Does PTCA in acute myocardial infarction affect mortality and reinfarction rates? A quantitative overview (meta-analysis) of the randomized clinical trials
32. Reokklusion nach erfolgreicher thrombolytischer therapie beim akuten myokardinfarkt
33. Improved thrombolysis in acute myocardial infarction with front-loaded administration of alteplase: Results of the rtPA-APSAC patency study (TAPS)
34. Importance of infarct-related artery patency for recovery of left ventricular function and late survival after primary angioplasty for acute myocardial infarction
35. Angiographic evolution of intracoronary thrombus and dissection following percutaneous transluminal coronary angioplasty in unstable angina (TAUSA) trial
36. Thrombosis of a flexible coil coronary stent: Frequency, predictors and clinical outcome
37. Clinical and angiographic implications of coronary stenting in thrombus-containing lesions
38. Comparison of primary coronary stenting to primary balloon angioplasty with stent bailout for the treatment of patients with acute myocardial infarction
39. Variations between countries in invasive cardiac procedures and outcomes in patients with suspected unstable angina or myocardial infarction without initial ST elevation